Individual approach in treating patients with pulmonary and tracheobronchial tuberculosis, with a long history of tobacco smoking and decompensated diabetes mellitus

Introduction. At the end of 2020, the clinical cure rate in all registration groups of patients with pulmonary tuberculosis was 48.2 %. There is now ample evidence that additional risk factors influence the more severe course of pulmonary tuberculosis and reduce the effectiveness of standard anti-tuberculosis therapeutic programs. Diabetes mellitus and tobacco use are among the significant risk factors. Complementing standard TB therapeutic programs with nicotine addiction and diabetes mellitus treatment programs with the formation of an individual comprehensive patient treatment plan will increase the effectiveness of TB treatment. Thus, the goal of this work is to demonstrate the high effectiveness of an individualized approach to the treatment of a patient with pulmonary tuberculosis with a comorbid background.

The aim of the work was to demonstrate the high effectiveness of an individualized approach to the treatment of a patient with pulmonary tuberculosis with a comorbid background.

Materials and methods At the Central TB Research Institute the patient underwent a comprehensive examination, including mandatory, additional and facultative methods of investigation. Based on the findings, the patient underwent complex treatment: antituberculosis chemotherapy, correction of carbohydrate metabolism disorders using oral antidiabetic drugs, nicotine replacement therapy according to the selected scheme, taking into account the degree of nicotine addiction.

Results and Discussion Against the background of complex treatment, by four months of therapy the following was achieved: knockdown of systemic inflammatory reactions, cessation of bacterial excretion, compensation of diabetes mellitus. X-ray examination revealed closure of a large decay cavity, resorption and consolidation of focal infiltrative changes. There was regression of infiltrative changes of trachea and bronchi. The patient completely stopped using tobacco due to nicotine replacement therapy.

Conclusion This clinical example demonstrates the high effectiveness of an individualized approach to the treatment of tuberculosis, including the need for an individualized regimen of anti-tuberculosis therapy, adequate compensation for diabetes mellitus, and the implementation of relevant smoking cessation techniques among smokers with pulmonary tuberculosis.

1. Нечаева О.Б. Состояние и перспективы противотуберкулезной службы России в период COVID-19. Туберкулез и болезни легких. 2020;98(12):7–19.

2. Ресурсы и деятельность противотуберкулезных организаций Российской Федерации в 2019–2020 гг. Статистические материалы / О.Б. Нечаева, И.М. Сон, А.В. Гордина, С.А. Стерликов, Д.А. Кучерявая, А.В. Дергачев, С.Б. Пономарев. М.: ЦНИИОИЗ, 2021. 112 с.

3. International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017. URL: http://www.diabetesatlas.org (дата обращения: 03.10.2022).

4. Комиссарова О.Г., Абдуллаев Р.Ю., Алешина С.В., Романов В.В. Клинические проявления и эффективность лечения туберкулеза легких с множественной лекарственной устойчивостью возбудителя у больных сахарным диабетом. Российский медицинский журнал. 2018;24(5):254–257. https://doi.org/10.18821/0869-2106-2018-24-5-254-257.

5. Sander L, Gilman, Xun Z. Smoke: A global history of smoking. London: Reaktion Books; 2004. pp. 408. https://doi.org/10.1017/S002572730000990X.

6. Bai X., Stitzel J.A., Bai A. et al. Nicotine Impairs Macrophage Control of Mycobacterium tuberculosis. Am J Respir Cell Mol Biol. 2017;57(3):324–333. https://doi.org/10.1165/rcmb.2016-0270OC.

7. Kruijshaar M.E., Lipman M., Essink-Bot M.L. et al. Health status of UK patients with active tuberculosis. Int J Tuberc Lung Dis. 2010;14(3):296–302.

8. Чумоватов Н.В., Антонов Н.С., Сахарова Г.М. с соавт. Количественная оценка связи табакокурения и туберкулеза легких. Профилактическая медицина. 2022;25(1):48–53. https://doi.org/10.17116/profmed20222501148.

9. IDF Diabetes Atlasт Eighth Edition 2017. IDF [Official website]. URL: http://www.idf.org/diabetesatlas.

10. Комиссарова О.Г., Абдуллаев Р.Ю., Михайловский А.М. Сахарный диабет как фактор риска развития туберкулеза: патофизиологические аспекты. Медицинский альянс. 2017;3:28–34.

11. Смурова Т.Ф., Ковалева С.И. Туберкулез и сахарный диабет. М.: Медкнига; 2007. 317 с.

12. Jeon C.Y., Murray M.B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152. https://doi.org/10.1371/journal.pmed.0050152.

13. Комиссарова О.Г., Абдуллаев Р.Ю., Коняева О.О., Михайловский А.М. Распространенность, клинические проявления и эффективность лечения туберкулеза у больных сахарным диабетом. Врач. 2017;2:24–28.

14. Pablos-Méndez A., Blustein J., Knirsch C.A. The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics. Am J Public Health. 1997;87(4):574–579. https://doi.org/10.2105/ajph.87.4.574.

15. Дедов И.И. Инновационные технологии в лечении и профилактике сахарного диабета и его осложнений. Сахарный диабет. 2013;3:4–10.

16. Яблонский П.К., Суховская О.А. Туберкулез и табакокурение. Актуальные проблемы и перспективы развития противотуберкулезной службы в Российской Федерации. В кн.: Материалы I Конгресса Национальной ассоциации фтизиатров. СПб., 2012. С. 322–323. URL: http://tb-hiv.ru/images/cms/data/docpdf/tb-hiv_matherials.pdf (дата обращения: 01.11.2022).

17. Brunet L., Pai M., Davids V. et al. High prevalence of smoking among patients with suspected tuberculosis in South Africa. Eur Respir J. 2011;38(1):139–146. https://doi.org/10.1183/09031936.00137710.

18. Gegia M., Magee M.J., Kempker R.R. et al. Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia. Bull World Health Organ. 2015;93(6):390–399. https://doi.org/10.2471/BLT.14.147439.

19. Safa M., Tabarsi P., Sharifi H. Pattern of tobacco consumption among TB patients in a tuberculosis referral center. Tanaffos. 2011;10(2):50–55.

20. Глобальный опрос взрослого населения о пользовании табачными изделиями. Российская Федерация. М.: Росстат, 2009. 172 с.